Your browser is no longer supported. Please, upgrade your browser.
BAX [NYSE]
Baxter International Inc.
IndexS&P 500 P/E37.04 EPS (ttm)2.18 Insider Own0.10% Shs Outstand503.00M Perf Week-2.92%
Market Cap40.20B Forward P/E20.32 EPS next Y3.98 Insider Trans-7.57% Shs Float499.00M Perf Month8.40%
Income1.12B PEG3.20 EPS next Q0.94 Inst Own89.30% Short Float1.27% Perf Quarter-0.75%
Sales12.20B P/S3.30 EPS this Y37.10% Inst Trans0.32% Short Ratio1.89 Perf Half Y-3.14%
Book/sh16.89 P/B4.78 EPS next Y12.83% ROA5.70% Target Price93.64 Perf Year3.14%
Cash/sh6.30 P/C12.82 EPS next 5Y11.57% ROE13.10% 52W Range73.12 - 88.32 Perf YTD0.69%
Dividend1.12 P/FCF47.02 EPS past 5Y24.40% ROI8.60% 52W High-8.37% Beta0.64
Dividend %1.39% Quick Ratio1.80 Sales past 5Y3.20% Gross Margin39.60% 52W Low10.68% ATR1.45
Employees50000 Current Ratio2.40 Sales Q/Q14.00% Oper. Margin12.60% RSI (14)53.91 Volatility1.36% 1.90%
OptionableYes Debt/Eq0.73 EPS Q/Q23.00% Profit Margin9.20% Rel Volume0.43 Prev Close80.79
ShortableYes LT Debt/Eq0.67 EarningsJul 29 BMO Payout45.90% Avg Volume3.34M Price80.93
Recom2.20 SMA200.60% SMA503.17% SMA2000.34% Volume1,216,497 Change0.17%
Sep-13-21Upgrade Cowen Market Perform → Outperform $98
Sep-03-21Upgrade Barclays Equal Weight → Overweight $93 → $100
May-25-21Initiated Barclays Equal Weight $93
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $100 → $80
Jan-06-21Downgrade UBS Buy → Neutral $95 → $85
Dec-15-20Downgrade Goldman Buy → Neutral $96 → $85
Oct-01-20Upgrade Citigroup Neutral → Buy $94
Sep-04-20Downgrade Argus Buy → Hold
Jun-24-20Initiated Oppenheimer Outperform $100
Mar-19-20Upgrade Stifel Hold → Buy $87 → $95
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $92
Mar-05-20Initiated Citigroup Neutral $94
Feb-13-20Initiated Goldman Buy $104
Jan-02-20Upgrade Evercore ISI In-line → Outperform $80 → $94
Dec-17-19Downgrade Morgan Stanley Overweight → Equal-Weight $90 → $88
Jun-26-19Initiated KeyBanc Capital Markets Sector Weight
Apr-08-19Downgrade Evercore ISI Outperform → In-line
Jan-02-19Upgrade Morgan Stanley Underweight → Overweight
Jan-02-19Upgrade Citigroup Neutral → Buy
Nov-02-18Upgrade Argus Hold → Buy
Sep-23-21 11:24AM  
09:00AM  
Sep-09-21 08:00AM  
Sep-06-21 10:51AM  
Sep-04-21 08:36AM  
Sep-03-21 06:03PM  
12:04PM  
10:33AM  
09:57AM  
Sep-02-21 03:43PM  
01:34PM  
09:52AM  
08:41AM  
07:19AM  
07:14AM  
07:00AM  
04:03AM  
03:52AM  
Aug-30-21 01:10PM  
11:53AM  
08:16AM  
05:28AM  
01:35AM  
Aug-29-21 06:59PM  
06:40PM  
Aug-18-21 08:30AM  
Aug-13-21 06:54AM  
Aug-11-21 09:19AM  
07:00AM  
Aug-10-21 02:41PM  
09:47AM  
Aug-02-21 04:15PM  
Jul-29-21 06:45PM  
06:00PM  
04:15PM  
11:13AM  
08:45AM  
08:37AM  
08:00AM  
08:00AM  
07:15AM  
Jul-28-21 04:40PM  
12:10PM  
09:52AM  
Jul-23-21 07:53AM  
Jul-22-21 03:03PM  
Jul-15-21 08:00AM  
Jul-12-21 06:30PM  
Jul-09-21 10:13AM  
07:30AM  
Jul-08-21 09:06AM  
08:00AM  
Jul-07-21 09:02AM  
08:36AM  
Jul-06-21 08:53AM  
Jun-29-21 09:57AM  
08:00AM  
Jun-28-21 10:13AM  
01:51AM  
Jun-24-21 04:48PM  
Jun-15-21 04:15PM  
Jun-09-21 10:30AM  
Jun-08-21 08:30AM  
Jun-07-21 08:11AM  
Jun-02-21 08:30AM  
Jun-01-21 08:45AM  
May-29-21 03:13AM  
May-25-21 08:00AM  
May-20-21 06:23PM  
May-17-21 02:22AM  
May-10-21 04:44PM  
04:32PM  
May-08-21 07:30AM  
May-04-21 04:15PM  
May-03-21 05:00PM  
Apr-29-21 01:00PM  
09:00AM  
08:25AM  
07:15AM  
Apr-28-21 09:13AM  
Apr-26-21 12:10PM  
08:18AM  
Apr-22-21 12:33PM  
Apr-21-21 09:45AM  
08:00AM  
Apr-17-21 03:43AM  
Apr-12-21 03:58PM  
Apr-07-21 04:15PM  
Mar-30-21 04:15PM  
Mar-29-21 03:55PM  
10:00AM  
09:00AM  
Mar-24-21 04:15PM  
Mar-18-21 01:50AM  
Mar-16-21 08:56AM  
Mar-12-21 08:00AM  
Mar-10-21 04:15PM  
Mar-08-21 09:46AM  
09:21AM  
09:14AM  
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martin SeanSVP and General CounselAug 02Option Exercise50.7719,8001,005,24661,977Aug 04 04:09 PM
Martin SeanSVP and General CounselAug 02Sale77.2619,8001,529,74842,177Aug 04 04:09 PM
Frye AndrewSVP, President, APACApr 12Sale84.7910,999932,6059,041Apr 14 04:04 PM
HELLMAN PETER SDirectorApr 05Option Exercise31.264,990155,98730,389Apr 07 06:55 PM
STROUCKEN ALBERT P LDirectorApr 05Option Exercise31.264,990155,98736,886Apr 07 06:57 PM
STROUCKEN ALBERT P LDirectorApr 05Sale84.564,990421,95431,896Apr 07 06:57 PM
HELLMAN PETER SDirectorApr 05Sale84.564,990421,95425,399Apr 07 06:55 PM
Martin SeanSVP and General CounselNov 02Option Exercise50.7747,0012,386,24186,641Nov 04 04:05 PM
Martin SeanSVP and General CounselNov 02Sale78.6747,0013,697,79439,640Nov 04 04:05 PM